Open AccessGlycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Author(s) -
Steven E. Kahn,
Steven M. Haffner,
Mark Heise,
William H. Herman,
Rury R. Holman,
Nigel C. Jones,
Barbara G. Kravitz,
John M. Lachin,
Mark O’Neill,
Bernard Zinman,
Giancarlo Viberti
Publication year - 2006
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa066224
Subject(s) - medicine , rosiglitazone , metformin , glycemic , diabetes mellitus , intensive care medicine , pharmacology , endocrinology
The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom